A fatal condition in the thoracic aorta. What's your diagnosis? Floating aortic thrombus.

Ann Saudi Med

Dr. Ruken Yuksekkaya, Radiology Department,, Gaziosmanpasa University School of Medicine,, Tokat, Turkey ., Gaziosmanpasa Universitesi Tip Fakultesi Radyoloji AD,, Tokat, Turkey, T: + 90 532 7174634, F: + 90 356 2129417,

Published: August 2014

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6074892PMC
http://dx.doi.org/10.5144/0256-4947.2013.508DOI Listing

Publication Analysis

Top Keywords

fatal condition
4
condition thoracic
4
thoracic aorta
4
aorta what's
4
what's diagnosis?
4
diagnosis? floating
4
floating aortic
4
aortic thrombus
4
fatal
1
thoracic
1

Similar Publications

Fatal familial insomnia: A new case description with response to thoracic sympathetic nerve thermocoagulation and stellate ganglion block.

Sleep Med

December 2024

Department of Neurology, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, Henan Province, China. Electronic address:

Fatal familial insomnia (FFI) is a rare autosomal dominant neurodegenerative disorder characterized by rapidly progressive dementia, severe sleep disturbances, and autonomic dysfunction. The clinical manifestations of FFI can exhibit substantial variations, making it crucial to rule out other conditions, such as autoimmune encephalitis and Creutzfeldt-Jakob disease, during early diagnosis. In this study, we describe the case of a 58-year-old man who experienced persistent insomnia, autonomic symptoms, gait instability, and rapidly progressive dementia.

View Article and Find Full Text PDF

Enhancing Construction Safety Through Workplace Surveillance and Systematic Follow-Ups.

Am J Ind Med

January 2025

EHS Department, M&M SBG, L&T Construction (Larsen &Toubro), Kolkata, West Bengal, India.

Background: Globally, construction jobs are associated with serious occupational safety and health (OSH) risks. In large construction projects, managing OSH risks is challenging due to a multitude of factors, and it is important to have sound management strategies and innovative solutions to tackle these ever-evolving OSH risks. Safety surveillance plays a pivotal role in accident prevention in the construction industry.

View Article and Find Full Text PDF

Mesenchymal stem cell therapy as a game-changer in liver diseases: review of current clinical trials.

Stem Cell Res Ther

January 2025

School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, 10F., Teaching & Research Building, Shuang-Ho Campus, No. 301, Yuantong Rd., Zhonghe Dist., Taipei, 235, Taiwan.

Chronic liver diseases, including cirrhosis and liver failure, remain formidable challenges due to their complex progression and limited therapeutic options. Mesenchymal stem cell (MSC) therapy has emerged as a game-changing approach, leveraging its potent immunomodulatory, anti-fibrotic, and regenerative capabilities, along with the ability to transdifferentiate into hepatocytes. This review delves into the latest advances in MSC-based treatments for chronic and end-stage liver diseases, as highlighted in current clinical trials.

View Article and Find Full Text PDF
Article Synopsis
  • Diabetic foot ulcers (DFUs) can lead to severe complications like amputation if not treated promptly, often due to delays in care.
  • A 56-year-old patient experienced a DFU linked to a bacterial infection from poultry exposure, requiring multiple debridement surgeries and targeted antibiotic treatment.
  • Effective management of DFUs involves adjusting antibiotic therapies based on identified pathogens to reduce mortality and prevent irreversible amputations.
View Article and Find Full Text PDF

The term Raynaud's phenomenon (RP) is used to describe complex symptoms related to vascular compromise, which are typically exacerbated by cold-induced vasoconstriction, emotional stress, or other sympathomimetic factors. In almost all patients with limited cutaneous systemic sclerosis (SSc), the first symptom is RP, often two to five years before any other symptom of scleroderma. The clinical course and severity of this disease are variable and highly fatal in some individuals, which has led to the development of strategies for timely diagnosis; hence, criteria for the very early diagnosis of systemic sclerosis have been established.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!